Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Minimal Residual Disease (MRD)35.28M81.69%
Immune Medicine7.91M18.31%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States170.28M100.00%